About ProMed DME
ProMed DME is a company based in Stuart (United States) founded in 2020 was acquired by NMS Capital in July 2024. It operates as a Direct-to-Consumer (D2C) and Subscription Services. ProMed DME offers products and services including Diabetic Supplies, Urinary Catheters, and Wound Care Products.
- Headquarter Stuart, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Strive Medical Diabetes
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
NMS Capital
(Jul 08, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ProMed DME
ProMed DME offers a comprehensive portfolio of products and services, including Diabetic Supplies, Urinary Catheters, and Wound Care Products.
Supplies for diabetes management are provided to patients.
Catheters for urinary incontinence are offered to users.
Products for wound healing are supplied to customers.
Funding Insights of ProMed DME
Detailed funding history for ProMed DME
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ProMed DME
ProMed DME has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NMS Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NMS Capital is engaged in strategic equity investments for growth companies.
|
Locked | Locked | Locked |
Investor details for ProMed DME
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProMed DME
Investment portfolio details for ProMed DME
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ProMed DME
Detailed financials for ProMed DME
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Promed Dme Comparisons
Peer comparison for ProMed DME
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ProMed DME
Detailed competitors of ProMed DME
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Promed Dme
Complete news archive for ProMed DME
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProMed DME
ProMed DME was founded in 2020.
ProMed DME is headquartered in Stuart, United States. It is registered at Stuart, Florida, United States.
Michael Breslin is the current CEO of ProMed DME.
Durable medical equipment and supplies are distributed by ProMed DME, now part of Strive Medical Diabetes. Focus is placed on diabetes management, urinary incontinence, and wound care solutions. Products are delivered directly to customers with free shipping. Support is offered through dedicated nurses and product specialists. The company serves patients across the United States, accepting most insurance plans including Medicare and Medicaid. Comprehensive care and convenience are ensured through streamlined ordering and reordering processes.
ProMed DME offers Diabetic Supplies, Urinary Catheters, and Wound Care Products.
ProMed DME has 1 investor. Key investors include NMS Capital.